文献速递妇科

早期宫颈癌患者根治性子宫切除术前接受宫颈锥切术:一项韩国多中心研究(COBRA-R)

Conization before radical hysterectomy in patients with early-stage cervical cancer: A Korean multicenter study (COBRA-R).
PubMed 文献 · Gynecol Oncol · 2023-04-25

该多中心研究纳入2006至2021年间韩国六家机构接受初次C型根治性子宫切除术的2009 FIGO IB1期、淋巴结阴性、切缘阴性、宫旁阴性的宫颈癌患者1254例,按肿瘤大小、手术方式和病理类型分组后进行1:1倾向评分匹配,比较锥切组与非锥切组的生存结局。结果显示,在肿瘤>2 cm且接受微创根治性子宫切除术的患者中,锥切组3年无病生存率显著优于非锥切组,而肿瘤≤2 cm者两组无差异。

要点

  • 肿瘤>2 cm、微创根治性子宫切除的鳞癌患者,锥切组3年DFS 96.3% vs 非锥切组87.4%(P=0.007)。
  • 同条件下非鳞癌患者,锥切组3年DFS 97.0% vs 非锥切组74.8%(P=0.021)。
  • 肿瘤≤2 cm者无论手术方式或病理类型,锥切与非锥切组DFS均无差异。

核心结论

  • 在肿瘤>2 cm且接受初次微创根治性子宫切除术的早期宫颈癌患者中,宫颈锥切与较低的复发率相关。
  • 作者认为,可在微创根治性子宫切除术前进行宫颈锥切以尽量减少子宫残留肿瘤。

研究设计与样本

  • 韩国六家机构的多中心研究,纳入2006至2021年间接受初次C型根治性子宫切除术的2009 FIGO IB1期、淋巴结阴性、切缘阴性、宫旁阴性宫颈癌患者。
  • 共纳入1254例患者,其中锥切组355例、非锥切组899例,按肿瘤大小、手术方式和病理类型分组后进行系列独立1:1倾向评分匹配。

主要发现

  • 在肿瘤>2 cm且接受微创根治性子宫切除术的匹配患者中,鳞癌患者锥切组3年无病生存率96.3% vs 非锥切组87.4%(P=0.007)。
  • 在肿瘤>2 cm且接受微创根治性子宫切除术的匹配患者中,非鳞癌患者锥切组3年无病生存率97.0% vs 非锥切组74.8%(P=0.021)。
  • 在肿瘤≤2 cm的匹配患者中,无论手术方式或病理类型,锥切组与非锥切组无病生存率均无差异。
  • 在接受微创根治性子宫切除术的患者中,无病生存率随残留肿瘤增大而显著恶化(P<0.001)。

临床怎么用

  • 作者认为,宫颈锥切可在微创根治性子宫切除术前进行,以尽量减少子宫残留肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the impact of conization on survival outcomes and to identify a specific population that might benefit from conization before radical hysterectomy (RH) in patients with early-stage cervical cancer. METHODS: From six institutions in Korea, we identified node-negative, margin-negative, parametria-negative, 2009 FIGO stage IB1 cervical cancer patients who underwent primary type C RH between 2006 and 2021. The patients were divided into multiple groups based on tumor size, surgical approach, and histology. We performed a series of independent 1:1 propensity score matching and compared the survival outcomes between the conization and non-conization groups. RESULTS: In total, 1254 patients were included: conization (n = 355) and non-conization (n = 899). Among the matched patients with a tumor size of >2 cm, the conization group showed a significantly better 3-year disease-free survival (DFS) rate compared with the non-conization group when RH was conducted via minimally invasive surgery (MIS), in those with squamous cell carcinoma (96.3% vs. 87.4%, P = 0.007) and non-squamous cell carcinoma (97.0% vs. 74.8%, P = 0.021). However, no difference in DFS was observed between the two groups among the matched patients with a tumor size of ≤2 cm, regardless of surgical approach or histological type. In patients who underwent MIS RH, DFS significantly worsened as the residual tumor size increased (P < 0.001). CONCLUSION: Cervical conization was associated with a lower recurrence rate in patients with early-stage cervical cancer with a tumor size of >2 cm who underwent primary MIS RH. Cervical conization may be performed prior to MIS RH to minimize the uterine residual tumor.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Kim SI, Nam SH, Hwangbo S, et al. Conization before radical hysterectomy in patients with early-stage cervical cancer: A Korean multicenter study (COBRA-R). Gynecol Oncol. 2023. PMID: 37105062. doi:10.1016/j.ygyno.2023.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。